JoVE Logo

S'identifier

Vous avez un accès complet à ce contenu via

Nanyang Technological University

Performing Double Fluorescence In Situ Hybridization to Detect Gene Expression in Mouse Brain Sections

-- views • 1:30 min

Transcription

Take a chemically-fixed mouse brain section.

Add a hybridization mixture containing a permeabilization agent and RNA probes labeled with FITC or DIG.

Incubate to allow cell permeabilization and probe entry.

The probes bind to complementary sequences on MBP mRNA, a reference marker ubiquitously expressed in oligodendrocytes, or ASPA mRNA, the target.

Wash to remove unbound probes.

Add a blocking buffer to prevent non-specific antibody binding.

Introduce HRP-conjugated anti-FITC antibodies targeting the FITC-labeled probe.

Wash, then add FITC-tyramide.

HRP oxidizes FITC-tyramide into a highly reactive form that binds to nearby proteins, amplifying the fluorescence signal.

Wash and reintroduce the blocking buffer.

Add alkaline phosphatase-conjugated anti-DIG antibodies targeting the DIG-labeled probe.

Wash and apply the Fast Red solution.

Alkaline phosphatase dephosphorylates Fast Red, producing a fluorescent precipitate.

Visualize under a fluorescence microscope.

Co-localization of Mbp and ASPA signals indicates ASPA expression in oligodendrocytes.

article

02:36

Performing Double Fluorescence In Situ Hybridization to Detect Gene Expression in Mouse Brain Sections

Vidéos Associées

3 Views

article

11:22

Analyse quantitative de l’épissage alternatif pré-ARNm dans les Sections de cerveau de souris à l’aide de RNA essai In Situ hybridation avec

Vidéos Associées

8.8K Views

article

09:30

Localisation des gènes des récepteurs odorants dans les antennes acridiennes par ARN

Vidéos Associées

8.0K Views

article

05:23

Visualisation du SARS-CoV-2 à l’aide de l’hybridation in situ par immuno-ARN-fluorescence

Vidéos Associées

6.0K Views

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.